Open‐label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors (English)
- New search for: Graff, Julie N.
- New search for: Higano, Celestia S.
- New search for: Hahn, Noah M.
- New search for: Taylor, Matthew H.
- New search for: Zhang, Bin
- New search for: Zhou, Xiaofei
- New search for: Venkatakrishnan, Karthik
- New search for: Leonard, E. Jane
- New search for: Sarantopoulos, John
- New search for: Graff, Julie N.
- New search for: Higano, Celestia S.
- New search for: Hahn, Noah M.
- New search for: Taylor, Matthew H.
- New search for: Zhang, Bin
- New search for: Zhou, Xiaofei
- New search for: Venkatakrishnan, Karthik
- New search for: Leonard, E. Jane
- New search for: Sarantopoulos, John
In:
Cancer
;
122
, 16
;
2524-2533
;
2016
- Article (Journal) / Electronic Resource
-
Title:Open‐label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors
-
Contributors:Graff, Julie N. ( author ) / Higano, Celestia S. ( author ) / Hahn, Noah M. ( author ) / Taylor, Matthew H. ( author ) / Zhang, Bin ( author ) / Zhou, Xiaofei ( author ) / Venkatakrishnan, Karthik ( author ) / Leonard, E. Jane ( author ) / Sarantopoulos, John ( author )
-
Published in:Cancer ; 122, 16 ; 2524-2533
-
Publisher:
-
Publication date:2016-08-15
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 122, Issue 16
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2443
-
Issue Information – TOC – Masthead| 2016
- 2450
-
Publication Schedule| 2016
- 2451
-
FDA approves several diagnostic tests for cancerPrintz, Carrie et al. | 2016
- 2452
-
High fruit intake, lower alcohol consumption associated with lower breast cancer riskPrintz, Carrie et al. | 2016
- 2453
-
NCI seeks ideas for National Cancer MoonshotPrintz, Carrie et al. | 2016
- 2454
-
Hepatocellular carcinoma: How can we move from racial/ethnic disparities to a model of health equity?Singal, Amit G. / Yopp, Adam C. et al. | 2016
- 2457
-
Improving the patient experience in the delivery of high quality surgical care and health outcomesKim, Simon P. / Abouassaly, Robert et al. | 2016
- 2459
-
Improving the quality of survivorship for older adults with cancerMohile, Supriya G. / Hurria, Arti / Cohen, Harvey J. / Rowland, Julia H. / Leach, Corinne R. / Arora, Neeraj K. / Canin, Beverly / Muss, Hyman B. / Magnuson, Allison / Flannery, Marie et al. | 2016
- 2469
-
The role of 5‐aminolevulinic acid in enhancing surgery for high‐grade glioma, its current boundaries, and future perspectives: A systematic reviewMansouri, Alireza / Mansouri, Sheila / Hachem, Laureen D. / Klironomos, George / Vogelbaum, Michael A. / Bernstein, Mark / Zadeh, Gelareh et al. | 2016
- 2479
-
Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacityJoseph, Djenaba A. / Meester, Reinier G. S. / Zauber, Ann G. / Manninen, Diane L. / Winges, Linda / Dong, Fred B. / Peaker, Brandy / van Ballegooijen, Marjolein et al. | 2016
- 2487
-
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin‐converting enzyme inhibitors or angiotensin receptor blockersMorris, Zachary S. / Saha, Sandeep / Magnuson, William J. / Morris, Brett A. / Borkenhagen, Jenna F. / Ching, Alisa / Hirose, Gayle / McMurry, Vanesa / Francis, David M. / Harari, Paul M. et al. | 2016
- 2496
-
Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancerHalpern, Joshua A. / Sedrakyan, Art / Hsu, Wei‐Chun / Mao, Jialin / Daskivich, Timothy J. / Nguyen, Paul L. / Golden, Encouse B. / Kang, Josephine / Hu, Jim C. et al. | 2016
- 2505
-
Outcomes of patients with chronic lymphocytic leukemia treated with first‐line idelalisib plus rituximab after cessation of treatment for toxicityThompson, Philip A. / Stingo, Francesco / Keating, Michael J. / Ferrajoli, Alessandra / Burger, Jan A. / Wierda, William G. / Kadia, Tapan M. / O'Brien, Susan M. et al. | 2016
- 2512
-
Race/ethnicity‐specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United StatesHa, John / Yan, Melissa / Aguilar, Maria / Bhuket, Taft / Tana, Michele M. / Liu, Benny / Gish, Robert G. / Wong, Robert J. et al. | 2016
- 2524
-
Open‐label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumorsGraff, Julie N. / Higano, Celestia S. / Hahn, Noah M. / Taylor, Matthew H. / Zhang, Bin / Zhou, Xiaofei / Venkatakrishnan, Karthik / Leonard, E. Jane / Sarantopoulos, John et al. | 2016
- 2534
-
Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population‐based studyFlemming, Jennifer A. / Zhang‐Salomons, Jina / Nanji, Sulaiman / Booth, Christopher M. et al. | 2016
- 2544
-
Long‐term soy consumption and tumor tissue MicroRNA and gene expression in triple‐negative breast cancerGuo, Xingyi / Cai, Qiuyin / Bao, Pingping / Wu, Jie / Wen, Wanqing / Ye, Fei / Zheng, Wei / Zheng, Ying / Shu, Xiao‐Ou et al. | 2016
- 2552
-
Influence of the treatment facility volume on the survival of patients with non‐Hodgkin lymphomaGo, Ronald S. / Al‐Hamadani, Mohammed / Shah, Nilay D. / Crowson, Cynthia S. / Holton, Sara J. / Habermann, Elizabeth B. et al. | 2016
- 2560
-
Cost‐effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidenceErenay, Fatih Safa / Alagoz, Oguzhan / Banerjee, Ritesh / Said, Adnan / Cima, Robert R. et al. | 2016
- 2571
-
Patient experience and quality of urologic cancer surgery in US hospitalsShirk, Joseph D. / Tan, Hung‐Jui / Hu, Jim C. / Saigal, Christopher S. / Litwin, Mark S. et al. | 2016
- 2579
-
Vulnerable elders survey and socioeconomic status predict functional decline and death among older women with newly diagnosed nonmetastatic breast cancerOwusu, Cynthia / Margevicius, Seunghee / Schluchter, Mark / Koroukian, Siran M. / Schmitz, Kathryn H. / Berger, Nathan A. et al. | 2016
- 2587
-
Parental preparedness for late effects and long‐term quality of life in survivors of childhood cancerGreenzang, Katie A. / Cronin, Angel M. / Mack, Jennifer W. et al. | 2016
- 2595
-
PMH 9907: Long‐term outcomes of a randomized phase 3 study of short‐term bicalutamide hormone therapy and dose‐escalated external‐beam radiation therapy for localized prostate cancerMcPartlin, Andrew J. / Glicksman, Rachel / Pintilie, Melania / Tsuji, Debbie / Mok, Gary / Bayley, Andrew / Chung, Peter / Bristow, Robert G. / Gospodarowicz, Mary K. / Catton, Charles N. et al. | 2016
- 2604
-
Reply to being a widower may be an indication for routine prostate‐specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff pointGomez, Scarlett Lin / Martínez, María Elena / Brooks, James D. / Cheng, Iona / Lichtensztajn, Daphne / Murphy, James D. et al. | 2016
- 2604
-
Being a widower may be an indication for routine prostate‐specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff pointLehrer, Steven / Rosenzweig, Kenneth E. et al. | 2016